“The Buzz” Show: Geovax Labs Inc. (NASDAQ: GOVX) Licensing Agreement with PNP Therapeutics | Financial Buzz

“The Buzz” Show: Geovax Labs Inc. (NASDAQ: GOVX) Licensing Agreement with PNP Therapeutics

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Geovax Labs Inc. Shares Rise 16% Following Licensing Agreement with PNP Therapeutics, Inc.”

Geovax Labs Inc. (NASDAQ: GOVX) climbed over 16% in premarket trading after it had entered into an Assignment and License Agreement with PNP Therapeutics, Inc. 

The license grants GeoVax exclusive rights to develop and commercialize Gedeptin®, a novel patented product for the treatment of solid tumors and exclusive worldwide rights to key intellectual property, including Gedeptin patents, know-how, regulatory filings, clinical materials, and trademarks.

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform.

For more information, please visit: Geovax Labs Inc.

About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!